GENTAG
GENTAG is a US private IP and technology development company that licenses patented low-cost disposable wireless smart skin patches and diagnostic sensors readable by any smartphone via NFC or Bluetooth, serving healthcare, pharmaceutical, cosmetics, and consumer IoT licensees.
- Company typePrivate
- Founded1997
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What GENTAG does
GENTAG is a privately held US intellectual-property and technology development company based in Washington, D.C., founded in 1997 by John Peeters, Ph.D., a Cambridge-trained applied biologist. The company has built a portfolio of 66 issued patents — held jointly with its wholly-owned patent subsidiary Altivera, LLC — covering low-cost, disposable wireless smart skin patches and diagnostic sensors readable by any smartphone via NFC or Bluetooth. Core technology spans skin patches (fever, pain-free diabetes, cardiac, drug delivery, cosmetics), wireless lab-on-a-chip molecular diagnostics, printable battery-less rapid tests, modular e-nose sensors, and the SensorLinker in-home compliance hub. AI is applied in targeted use cases including anomaly detection on cardiac data and biomarker-driven pre-disease detection.
GENTAG's product surface is organized around three licensing markets: IoT sensors, wearables, and advanced diagnostics and pharmaceuticals. Applications include healthcare monitoring, pharmaceutical drug compliance and clinical trial data collection, cosmetics and skin health, food safety, packaging tamper detection, and consumer IoT. The diabetes patch platform is offered for licensing across 28 European countries under European Patent EP1709750, and the company has identified 25 major markets for its patented wireless patches, some of which have been licensed to industry partners.
GENTAG monetizes its portfolio primarily through technology licensing and royalties, supplemented by custom sensor development and hardware sales of the SensorLinker hub. The firm sells exclusively to enterprise licensees and strategic partners rather than to end users, and is open to joint ventures for co-development of specific applications. The company is founder-controlled, with no disclosed institutional investment, and operates with a small team of 11-50 employees led by a science-heavy leadership group that includes a former Director of the US National Science Foundation.
GENTAG firmographics
Firmographics- Name
- GENTAG
- Legal name
- GENTAG, Inc.
- Website
- https://gentag.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GENTAG is a US private IP and technology development company that licenses patented low-cost disposable wireless smart skin patches and diagnostic sensors readable by any smartphone via NFC or Bluetooth, serving healthcare, pharmaceutical, cosmetics, and consumer IoT licensees.
- Ownership category
- akta.pro rank
GENTAG industry classification
Industry- Product category
- Medical Wearable Diagnostic Sensors
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Research and Development in Nanotechnology (541713)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
- akta.pro secondary industries
- Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where GENTAG is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Markets served
GENTAG business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
Revenue model
- Technology Licensing: Gentag licenses its patent portfolio covering 66 issued patents to selected companies for use in IoT sensors, wearables, and advanced diagnostics markets. Licensing arrangements cover specific geographic regions (e.g., 28 European countries for diabetes patches). The company is also open to joint ventures.
- Custom Sensor Development: The company develops custom wearable sensors, skin patches, and innovative disposable diagnostic devices for healthcare, consumer, pharmaceutical, and food industries on a custom basis.
- SensorLinker Product Platform: Customized in-home mobile compliance and diagnostics sensor hub integrating wireless sensors for health providers and pharmaceutical companies.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
GENTAG product offering
Product offeringCore offering
GENTAG develops and licenses low-cost, disposable wireless smart skin patches and biomarker diagnostic devices that deliver medical-grade readings (fever, glucose, cardiac, skin, drug delivery, IoT sensing) directly to any smartphone via NFC or Bluetooth. The company also offers lab-on-a-chip molecular diagnostics, disposable rapid immunoassay tests, modular e-nose chemical sensors, and the SensorLinker in-home compliance hub. Core revenue is generated by licensing its 66-patent portfolio and providing custom sensor development to healthcare, pharmaceutical, consumer, cosmetics, and food-safety partners worldwide.
Product overview
GENTAG offers a portfolio of low-cost, disposable smart skin patches combined with wireless NFC/Bluetooth sensor technology that communicate directly with smartphones for diagnostics and health monitoring. The core platform encompasses skin patches for fever detection, pain-free diabetes monitoring, cardiac monitoring, drug delivery, and cosmetics/skin health. Supporting the patch platform are disposable diagnostic technologies including lab-on-a-chip for molecular analysis, rapid tests for biomarker/allergen/infectious disease detection, and modular e-nose sensors for personalized allergen detection. The SensorLinker hub enables home drug compliance monitoring by aggregating sensor data and transmitting it to healthcare providers. The portfolio spans consumer IoT applications (food safety, cosmetics, consumer goods) and advanced medical diagnostics, all leveraging the company's 66 issued patents covering NFC cell phone sensor networks, wearables, and point-of-care testing technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- Fever Patch
Quantifiable outcome
- Wireless read ranges from inches to several miles depending on frequency and application
- +1 more outcomes
Companies that use GENTAG
Customer profileSegments4 records
Ideal customer profiles4 records
GENTAG technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature8 records
GENTAG partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Altivera, LLCAltivera, LLC is Gentag's patent holding company. Together, Gentag, Inc. and Altivera, LLC hold 66 issued patents covering cell phone-based consumer safety sensors, IoT sensors, and sensors for instant diagnostic tests.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
GENTAG competitors and assessment
Company assessmentDirect peers
- Dexcom: Continuous glucose monitoring leader (Dexcom G7) that competes directly with Gentag's pain-free diabetes patch and CGM roadmap in continuous, smartphone-linked glucose sensing.
- Medtronic: Operates the MiniMed insulin delivery franchise that overlaps Gentag's artificial-pancreas closed-loop insulin delivery patent and competes across diabetes monitoring and drug delivery.
- iRhythm Technologies: Maker of the Zio wearable cardiac monitor, directly comparable to Gentag's AI-powered cardiac skin patches for ambulatory, smartphone-compatible cardiac monitoring.
- VitalConnect: Wearable biosensor (VitalPatch) for continuous patient monitoring in hospital and remote settings — directly comparable to Gentag's disposable wireless sensor platform for clinical and RPM use cases.
Broad incumbents
- Abbott: Manufacturer of FreeStyle Libre, the dominant CGM platform and a direct competitor to Gentag's wireless diabetes patch, while also competing in connected diagnostics across its broader device portfolio.
- Philips (BioTelemetry / Cardiac Monitoring): Acquired BioTelemetry to become one of the largest remote cardiac monitoring operators, directly competing with Gentag's wireless cardiac patches for ambulatory ECG and RPM deployment.
Emerging players
- Senseonics: Implantable continuous glucose monitoring (Eversense) company pursuing long-duration CGM, a comparable commercial and regulatory bet to Gentag's next-gen pain-free diabetes monitoring IP.
- Biolinq: Developer of intradermal wearable biosensors that, like Gentag's disposable patches, target continuous, minimally invasive metabolite sensing for consumer and clinical use.
- Epicore Biosystems: Sweat-sensing wearable patch company (connected to Gatorade/PepsiCo), highly comparable to Gentag's disposable, smartphone-readable biomarker patches for hydration and skin health.
- Movano Health: Builds small wearable devices for continuous health metrics (including glucose, heart rate, blood pressure) that overlap with Gentag's multi-frequency, smartphone-readable wearables.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
GENTAG social profiles
Digital presenceGENTAG financial estimates
Financial estimateRevenue estimate
Valuation estimate
GENTAG leadership team
Management profileNumber of profiles
Profiles6 records
GENTAG subsidiaries and ownership
Company hierarchySubsidiaries1 record
GENTAG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GENTAG M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GENTAG
What does GENTAG do?
GENTAG develops and licenses low-cost, disposable wireless smart skin patches and biomarker diagnostic devices that deliver medical-grade readings (fever, glucose, cardiac, skin, drug delivery, IoT sensing) directly to any smartphone via NFC or Bluetooth. The company also offers lab-on-a-chip molecular diagnostics, disposable rapid immunoassay tests, modular e-nose chemical sensors, and the SensorLinker in-home compliance hub. Core revenue is generated by licensing its 66-patent portfolio and providing custom sensor development to healthcare, pharmaceutical, consumer, cosmetics, and food-safety partners worldwide.
Is GENTAG a public or private company?
GENTAG is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GENTAG founded?
GENTAG was founded in 1997. It employs 11 to 50 people.
Where is GENTAG based?
GENTAG is headquartered in Washington, United States, in the North America region.
How does GENTAG make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are custom Sensor Development and sensorLinker Product Platform.
Who are GENTAG's main competitors?
Direct peers on record are Dexcom, Medtronic, iRhythm Technologies and VitalConnect. Broad incumbents are Abbott and Philips (BioTelemetry / Cardiac Monitoring). Emerging players are Senseonics, Biolinq, Epicore Biosystems and Movano Health.
Does GENTAG have an API?
No public API is recorded for GENTAG.
What industry is GENTAG in?
GENTAG's product category is Medical Wearable Diagnostic Sensors. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of CRABAKAI, Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning). Its NAICS code is 3345 and its SIC code is 3841.